More than a dozen types of cancer are increasing in incidence among adults under 50 in the U.S. [1].

This trend signals a shifting public health burden that may require changes to screening ages and preventative care for younger generations. While older adults have seen a decline in certain cancers due to effective screening, younger populations are facing new risks.

Data indicates that early-onset disease has doubled over one generation [2]. This stands in contrast to older-adult incidence, which is falling. Experts said the decline in older populations is due to effective colonoscopic screening and precancerous polypectomy [2].

Global trends show a slightly different pattern, with a slight rise in early-onset cancer incidence since 1990 [3]. Despite the increase in new cases, there has been a significant decrease in mortality from these early-onset cancers [3].

Researchers have not yet found a single explanation for the rise [4]. Some proposed factors include shifts in the "exposome"—which includes sedentary behavior and the consumption of ultra-processed foods [5]. Rising obesity is also cited as a factor, contributing to a substantial increase in related deaths [3].

Family history remains a major risk factor for those under 50 [1]. Because the science is far from settled on the exact causes, health officials said the importance of knowing familial medical histories to identify high-risk individuals early is paramount [4].

Epidemiologists are racing to figure out why Gen X and millennials are seeing rising rates of cancer [4], but the specific drivers of this trend remain under investigation.

Early-onset disease has doubled over one generation

The divergence between rising incidence in young adults and falling incidence in older adults suggests that traditional screening windows may no longer be sufficient. While improved treatment has lowered mortality, the rise in cases linked to obesity and ultra-processed foods points to a systemic environmental and lifestyle shift that could outpace current preventative medicine.